Skip to content

Drug interactions

Erythromycin + Fostamatinib

Severity: Minor

Erythromycin and Fostamatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The active metabolite of fostamatinib inhibits P-glycoprotein and may increase erythromycin exposure. This could increase erythromycin adverse effects such as gastrointestinal upset and QT prolongation.

What this interaction means in plain words

Erythromycin and Fostamatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Erythromycin belongs to Anti Bacterial; Fostamatinib belongs to Oncology.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by the fostamatinib metabolite tamatinib reduces erythromycin efflux.

What to do

Monitor for erythromycin adverse effects and reduce the dose if toxicity occurs. Consider an alternative antibiotic in patients with QT risk factors.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erythromycin and Fostamatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erythromycin with Fostamatinib?

MediHelp rates the interaction as minor. Erythromycin and Fostamatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The active metabolite of fostamatinib inhibits P-glycoprotein and may increase erythromycin exposure. This could increase erythromycin adverse effects such as gastrointestinal upset and QT prolongation.

How serious is the interaction between Erythromycin and Fostamatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for erythromycin adverse effects and reduce the dose if toxicity occurs. Consider an alternative antibiotic in patients with QT risk factors.

What other medicines interact with Erythromycin?

MediHelp also lists interactions of Erythromycin with, for example, Conivaptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Erythromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in